Hjem › Hudlidelser › Texas
Hudlidelser kliniske forsøg i Texas
5 studier for Hudlidelser søger deltagere på steder i Texas.
Officiel studietekst (engelsk)
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
- The University of Texas MD Anderson Cancer Center, Houston
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04996875A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
- Dermatology Treatment and Research Center, Dallas
- Pediatric Dermatology of North Texas, Grapevine
- Texas Dermatology and Laser Specialists, San Antonio
- og 1 flere
RekruttererFase 3
Alder 6 til 17 · Alle køn · Opdateret 8. sep. 2026 · NCT05723198A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- Progressive Clinical Research, PA, San Antonio
RekruttererFase 2
Alder 18 til 65 · Alle køn · Opdateret 28. aug. 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 8, Southlake
RekruttererFase 2
Alder 18 til 74 · Alle køn · Opdateret 12. aug. 2026 · NCT07037901Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
- J&S Studies, Inc, College Station
- Pflugerville Dermatology Clinical Research Center, Inc. d/b/a Austin Institute for Clinical Research, Pflugerville
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 22. apr. 2026 · NCT07144852Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.